Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors

This publication has 63 references indexed in Scilit:

• Crystal Structure of Human Aurora B in Complex with INCENP and VX-680
  Journal of Medicinal Chemistry, 2012
• Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
  Cancer Chemotherapy and Pharmacology, 2012
• Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML
  Leukemia Research, 2012
• The role of conformational entropy in molecular recognition by calmodulin
  Nature Chemical Biology, 2010
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
  Journal of Computational Chemistry, 2009
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
  Journal of Computational Chemistry, 2009
• Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
  Proceedings of the National Academy of Sciences, 2007
• Development and testing of a general amber force field
  Journal of Computational Chemistry, 2004
• The cellular geography of Aurora kinases
  Nature Reviews Molecular Cell Biology, 2003
• Comparison of simple potential functions for simulating liquid water
  The Journal of Chemical Physics, 1983